Laboratorios Farmaceuticos Rovi, S.A. (ROVI)
Healthcare • Drug Manufacturers - Specialty & Generic
StockMCESpainES0157261019
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Laboratorios Farmaceuticos Rovi, S.A., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in EUR. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 13:47. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 24 Feb 2027 11:00 | — | — | — | Upcoming |
| 23 Feb 2022 07:00 | 0.61 | 0.66 | +8.2% | Beat |
| 26 Feb 2019 19:00 | -0.01 | 0.12 | +1,328.0% | Beat |
| 29 Apr 2015 05:00 | 0.11 | 0.11 | 0.0% | In line |
| 25 Feb 2015 22:00 | 0.09 | 0.08 | -7.4% | Miss |
| 06 Nov 2014 23:00 | 0.12 | 0.10 | -14.8% | Miss |
| 30 Jul 2014 10:00 | 0.13 | 0.18 | +34.5% | Beat |
| 29 Apr 2014 04:00 | 0.15 | 0.12 | -22.1% | Miss |
| 27 Feb 2014 09:00 | 0.13 | 0.06 | -52.0% | Miss |
| 07 Nov 2013 04:00 | 0.15 | 0.15 | 0.0% | In line |
| 31 Jul 2013 10:00 | 0.35 | 0.34 | -3.6% | Miss |
| 24 Apr 2013 06:00 | 0.25 | 0.11 | -56.0% | Miss |
| 21 Feb 2013 07:00 | 0.08 | 0.06 | -28.2% | Miss |
| 08 Nov 2012 07:00 | 0.14 | 0.07 | -49.4% | Miss |
| 26 Jul 2012 09:00 | 0.10 | 0.15 | +54.5% | Beat |
| 26 Apr 2012 09:00 | 0.12 | 0.12 | 0.0% | In line |
| 23 Feb 2012 12:00 | — | 0.05 | +2,477.3% | Beat |
| 08 Nov 2011 07:00 | 0.09 | 0.09 | 0.0% | In line |
| 28 Jul 2011 13:00 | 0.06 | 0.16 | +148.7% | Beat |
| 11 May 2011 13:00 | 0.05 | 0.05 | 0.0% | In line |
| 24 Feb 2011 07:00 | 0.02 | -0.16 | -933.3% | Miss |
| 29 Jul 2010 07:00 | 0.07 | 0.28 | +274.4% | Beat |
| 06 May 2010 06:00 | 0.09 | 0.09 | 0.0% | In line |
| 24 Feb 2010 01:00 | 0.14 | 0.06 | -57.1% | Miss |
| 12 Nov 2009 02:00 | 0.16 | 0.10 | -37.5% | Miss |
| 29 Jul 2009 01:00 | 0.11 | 0.04 | -63.6% | Miss |
| 26 Feb 2009 02:00 | 0.09 | 0.07 | -22.2% | Miss |
| 13 Nov 2008 03:00 | 0.16 | 0.17 | +9.7% | Beat |
| 29 Aug 2008 04:00 | 0.11 | 0.14 | +27.3% | Beat |
| 13 May 2008 11:00 | 0.13 | 0.09 | -28.0% | Miss |
| 07 Apr 2008 12:00 | 0.08 | -0.02 | -125.0% | Miss |
Annual results · EUR
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 743.5M | -2.7% | 140.4M | 18.9% | 2.75 | +2.8% | 119.3M |
| 2024 | 763.7M | -7.9% | 136.9M | 17.9% | 2.68 | -18.6% | 76.1M |
| 2023 | 829.5M | +1.4% | 170.3M | 20.5% | 3.29 | -11.9% | 58.1M |
| 2022 | 817.7M | — | 199.7M | 24.4% | 3.73 | — | 186.2M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 13 Nov 2026 | 70.00 | 70.15 | 69.55 | 69.80 | -0.50% | 25,774 | |
| 12 Nov 2026 | 71.00 | 71.50 | 70.05 | 70.15 | -0.78% | 67,313 | |
| 11 Nov 2026 | 69.90 | 71.00 | 69.75 | 70.70 | +1.87% | 193,357 | |
| 10 Nov 2026 | 69.75 | 69.75 | 68.60 | 69.40 | -0.07% | 93,155 | |
| 09 Nov 2026 | 68.85 | 69.75 | 68.25 | 69.45 | +1.24% | 120,273 | |
| 06 Nov 2026 | 68.30 | 68.60 | 66.45 | 68.60 | -0.65% | 202,557 | |
| 05 Nov 2026 | 65.70 | 70.15 | 65.70 | 69.05 | +8.31% | 610,840 | |
| 04 Nov 2026 | 63.15 | 64.10 | 62.50 | 63.75 | +0.87% | 127,699 | |
| 03 Nov 2026 | 63.45 | 63.95 | 63.00 | 63.20 | -0.16% | 101,175 | |
| 02 Nov 2026 | 62.15 | 63.55 | 62.05 | 63.30 | +1.20% | 118,719 | |
| 1,274 older periods: create a free account to see the whole history | |||||||
Prices in EUR, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Strong Earnings Report Might Change The Case For Investing In ROVI Stock (BME:ROVI) (opens in a new tab) Simply Wall St. · 07 Nov 2026 19:12
- Is Laboratorios Farmaceuticos Rovi (BME:ROVI) Undervalued Despite A 22% Three Year Gain? (opens in a new tab) Simply Wall St. · 19 Oct 2026 04:19
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 70.15 EUR
- Market cap
- 3.6B
- Dividend yield
- 1.37%
- 5-year average yield
- 1.42%
- Payout ratio
- 26%
- Last dividend
- 0.9594 EUR · 13 Jul 2026
- Exchange
- MCE
- Country
- Spain
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- EUR
Dividends
| Ex-dividend date | Per share |
|---|---|
| 13 Jul 2026 | 0.9594 EUR |
| 14 Jul 2025 | 0.9351 EUR |
| 08 Jul 2024 | 1.1037 EUR |
| 03 Jul 2023 | 1.2938 EUR |
| 8 older dividends: create a free account to see them | |
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Yield Dividends per year as a share of today's price. Very high yields count for less: they often signal trouble. | 5.7 / 25 |
|
| Dividend safety Can the company keep paying? The dividend against free cash flow and earnings, plus debt and interest cover. | 22.7 / 25 |
|
| Dividend growth How many years in a row the dividend has risen, and how fast. | 7.5 / 15 |
|
| Quality Return on equity, net margin and how stable the margins are. | 13.5 / 15 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 7.3 / 10 |
|
| Analysts How far the analysts' average target is from today's price. | 2.7 / 5 |
|
- Revenue has fallen two years in a row
Income profile: it pays a dividend, so it is scored mainly on the dividend and how safe it is. Based on 95% of the figures (grade A). Warnings take 6 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 17.45× | Fair | 30.56× |
| P/E (forward) | 21.29× | Fair | 14.16× |
| Price / book | 4.6× | Weak | 3.5× |
| Price / sales | 4.33× | Fair | 3.33× |
| EV / EBITDA | 18.58× | Weak | 11.19× |
| Free cash flow yield | 2.7% | Fair | 2.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 66.2% | Good | 54.9% |
| Operating margin | 20.2% | Good | 5.8% |
| Net margin | 24.8% | Good | 1.2% |
| Return on equity | 28.7% | Good | 4.4% |
| Return on assets | 10.2% | Good | 2.7% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | -3.1% | Weak | 10.1% |
| EPS growth / year | -9.7% | Weak | 10.2% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.13× | Good | 0.4× |
| Net debt / EBITDA | 0.15× | Good | 1.46× |
| Interest cover | 72.46× | Good | 2.17× |
| Current ratio | 2.68× | Good | 2.64× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 25.8% | Good | 0% |
| Payout of free cash flow | 49.2% | Good | 28.7% |
| Payout of free cash flow (3 years) | 68.4% | Fair | — |
| Dividend growth / year | 15.7% | Good | 6.5% |
| Years of rising dividends | 0 | Weak | 1.5 |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Similar shares
Follow ROVI and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.